- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 135.23M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 133.62M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 129.6M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.15M |
| Capex | Q1 2026 · Mar 31, 2025 | $536K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$11.85M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$18.65M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $594.85M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $581.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.18B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.17B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $312.78M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $318.62M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $358.51M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $367.24M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $851M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $831.23M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.59B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.6B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.17 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.17 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $60.56M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $66.7M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$9.46M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$22.39M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.03M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$26.63M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $237.82M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $254.1M |
| Revenue | Q1 2026 · Mar 31, 2026 | $320.87M |
| Revenue | Q1 2026 · Mar 31, 2025 | $325.71M |